Streetbeat News

Stock Prices

ONCO

Onconetix, Inc shares have resumed trading, which could indicate a resolution of previous issues that halted trading. Investors should monitor the stock for potential volatility.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:01 pm

RMD

ResMed (NYSE:RMD) has received varied analyst ratings over the past three months, with a recent average price target of $227.57, up 3.68% from the previous target. Analysts' ratings range from 'Outperform' to 'Underperform', reflecting diverse expectations for ResMed's market performance. The company, a leader in respiratory care devices, has shown strong financial health with a 9.01% revenue growth rate and a net margin of 23.89%.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:01 pm

NEO

NeoGenomics (NASDAQ:NEO) has received recent analyst ratings, with 3 analysts being bullish and 1 somewhat bullish. The average 12-month price target is $18.5. Despite revenue growth, NeoGenomics faces challenges with profitability and returns, as indicated by its net margin, ROE, and ROA being below industry averages.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

PCOR

Procore Technologies (NYSE:PCOR) has received diverse analyst ratings over the past three months, with a mix of bullish and neutral sentiments. The average 12-month price target has decreased by 14.63% to $70.69. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Despite a positive revenue growth rate of 24.42%, Procore faces challenges with profitability, ROE, and ROA, though it maintains a balanced debt approach.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

SPY

The House Price Index for July increased by 0.1%, which is below the estimated 0.2%. This indicates a slower growth in house prices than expected.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:00 pm

RDZN

Roadzen shares rose following the announcement of a one-year extension to its insider lock-up period.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:00 pm

DAY

Dayforce (NYSE:DAY) has received mixed analyst ratings over the past three months, with a majority being bullish or somewhat bullish. The average 12-month price target has slightly increased to $69.0. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Dayforce has shown strong revenue growth but faces challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

COMP

Compass (NYSE:COMP) has received varied analyst ratings over the past quarter, with a mix of bullish and somewhat bullish sentiments. Analysts have raised their price targets, indicating a positive outlook. The company's financial performance shows strong revenue growth and efficient cost management, but it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:00 pm

AYRWF

CURLF

TCNNF

Hispanic voters in Florida, who make up 22% of the electorate, are increasingly supporting cannabis legalization, with 60% backing Amendment 3. This trend could significantly impact the cannabis market in Florida, potentially leading to a 400% growth if the amendment passes. Key players like Trulieve, Curaleaf, and Ayr Wellness could benefit from this expansion.

Portfolio Pulse from Nicolás Jose Rodriguez

September 24, 2024 | 12:59 pm

SPOT

Spotify is launching an AI-powered playlist feature in beta for premium users on Android and iOS devices in the U.S., Canada, Ireland, and New Zealand.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 12:58 pm